Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory aml patients
American Journal of Hematology, 07/10/2012
Clinical Article
Scappini B et al. – The results suggest that clofarabine–citarabine regimen is effective in this particularly poor prognosis category of patients, representing a potential “bridge” toward bone marrow transplant procedures. Safety data were consistent with previously reported salvage therapies.



